Psoriatic Arthritis Treatment Trends and Forecast
The future of the global psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets. The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030 with a CAGR of 9.6% from 2024 to 2030. The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Psoriatic Arthritis Treatment by Segment
The study includes a forecast for the global psoriatic arthritis treatment by drugs class, route of administration , distribution channel, and region.
Psoriatic Arthritis Treatment Market by Drugs Class [Shipment Analysis by Value from 2018 to 2030]:
• Non-steroidal Anti-inflammatory Drugs
• Non-biologic Disease Modifying Anti-Rheumatic Drugs
• Biologic Disease Modifying Anti-Rheumatic Drugs
• Others
Psoriatic Arthritis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Oral
• Parenteral
• Topical
Psoriatic Arthritis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Psoriatic Arthritis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Psoriatic Arthritis Treatment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies psoriatic arthritis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the psoriatic arthritis treatment companies profiled in this report include-
• F. Hoffmann-La Roche
• Novartis
• Amgen
• Pfizer
• Johnson & Johnson Services
• Eli Lilly And Company
• Astrazeneca
• Sanofi
• Bristol-Myers Squibb Company
• Glaxosmithkline
Psoriatic Arthritis Treatment Market Insights
Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.
Within this market, hospital pharmacies will remain the largest segment.
APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.
Features of the Global Psoriatic Arthritis Treatment Market
Market Size Estimates: Psoriatic arthritis treatment market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Psoriatic arthritis treatment market size by drugs class, route of administration , distribution channel, and region in terms of value ($B).
Regional Analysis: Psoriatic arthritis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drugs class, route of administration , distribution channel, and regions for the psoriatic arthritis treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the psoriatic arthritis treatment market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the psoriatic arthritis treatment market size?
Answer: The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030.
Q.2 What is the growth forecast for psoriatic arthritis treatment market?
Answer: The global psoriatic arthritis treatment market is expected to grow with a CAGR of 9.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the psoriatic arthritis treatment market?
Answer: The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.
Q4. What are the major segments for psoriatic arthritis treatment market?
Answer: The future of the psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets.
Q5. Who are the key psoriatic arthritis treatment market companies?
Answer: Some of the key psoriatic arthritis treatment companies are as follows:
• F. Hoffmann-La Roche
• Novartis
• Amgen
• Pfizer
• Johnson & Johnson Services
• Eli Lilly and Company
• AstraZeneca
• Sanofi
• Bristol-Myers Squibb Company
• GlaxoSmithKline
Q6. Which psoriatic arthritis treatment market segment will be the largest in future?
Answer: Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.
Q7. In psoriatic arthritis treatment market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the psoriatic arthritis treatment market by drugs class (non-steroidal anti-inflammatory drugs, non-biologic disease modifying anti-rheumatic drugs, biologic disease modifying anti-rheumatic drugs, and others), route of administration (oral, parenteral, and topical), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Psoriatic Arthritis Treatment Market, Psoriatic Arthritis Treatment Market Size, Psoriatic Arthritis Treatment Market Growth, Psoriatic Arthritis Treatment Market Analysis, Psoriatic Arthritis Treatment Market Report, Psoriatic Arthritis Treatment Market Share, Psoriatic Arthritis Treatment Market Trends, Psoriatic Arthritis Treatment Market Forecast, Psoriatic Arthritis Treatment Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.